secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPID MICRO BIOSYSTEMS, INC. (RPID)
CIK:        0001380106
Form:       8-K
Filed at:   2026-08-07T11:02:16+00:00
Accession:  0001380106-26-000097
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rapid Micro Biosystems Q2 2026 revenue up 11% to $8.1M; gross margin record 15%
-------------------------------------------------------------------------------

- Q2 2026 total revenue $8.1M, +10.9% YoY; product $5.3M, service $2.8M, recurring $5.0M (+14.3%).
- Gross margin 15.0% vs 3.8% YoY; net loss $12.9M ($0.27/share) vs $11.9M loss ($0.27/share) prior year.
- Placed 4 Growth Direct systems, completed 9 validations; 200th system placed globally.
- Reaffirms FY2026 revenue guidance $37-41M, 30-38 placements, ~20% gross margin; raises validation guidance to at least 27.
- Cash, equivalents and short-term investments ~$20M as of June 30, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1380106/000138010626000097/0001380106-26-000097-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1380106/000138010626000097/rpid-20260807.htm
  HTML page:      https://secwatch.observer/filing/0001380106-26-000097

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer